These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Retigabine and gabapentin restore channel function and neuronal firing in a cellular model of an epilepsy-associated dominant-negative KCNQ5 variant. Krüger J; Lerche H Neuropharmacology; 2024 Jun; 250():109892. PubMed ID: 38428481 [TBL] [Abstract][Full Text] [Related]
4. Loss-of-Function and Gain-of-Function Mutations in KCNQ5 Cause Intellectual Disability or Epileptic Encephalopathy. Lehman A; Thouta S; Mancini GMS; Naidu S; van Slegtenhorst M; McWalter K; Person R; Mwenifumbo J; Salvarinova R; ; ; Guella I; McKenzie MB; Datta A; Connolly MB; Kalkhoran SM; Poburko D; Friedman JM; Farrer MJ; Demos M; Desai S; Claydon T Am J Hum Genet; 2017 Jul; 101(1):65-74. PubMed ID: 28669405 [TBL] [Abstract][Full Text] [Related]
5. De novo variants in KCNA3 cause developmental and epileptic encephalopathy. Soldovieri MV; Ambrosino P; Mosca I; Servettini I; Pietrunti F; Belperio G; ; Syrbe S; Taglialatela M; Lemke JR Ann Neurol; 2024 Feb; 95(2):365-376. PubMed ID: 37964487 [TBL] [Abstract][Full Text] [Related]
7. Nine patients with KCNQ2-related neonatal seizures and functional studies of two missense variants. Chokvithaya S; Caengprasath N; Buasong A; Jantasuwan S; Santawong K; Leela-Adisorn N; Tongkobpetch S; Ittiwut C; Saengow VE; Kamolvisit W; Boonsimma P; Bongsebandhu-Phubhakdi S; Shotelersuk V Sci Rep; 2023 Feb; 13(1):3328. PubMed ID: 36849527 [TBL] [Abstract][Full Text] [Related]
8. Distinct gene-set burden patterns underlie common generalized and focal epilepsies. Koko M; Krause R; Sander T; Bobbili DR; Nothnagel M; May P; Lerche H; EBioMedicine; 2021 Oct; 72():103588. PubMed ID: 34571366 [TBL] [Abstract][Full Text] [Related]
9. A Novel Kv7.3 Variant in the Voltage-Sensing S Miceli F; Carotenuto L; Barrese V; Soldovieri MV; Heinzen EL; Mandel AM; Lippa N; Bier L; Goldstein DB; Cooper EC; Cilio MR; Taglialatela M; Sands TT Front Physiol; 2020; 11():1040. PubMed ID: 33013448 [TBL] [Abstract][Full Text] [Related]
10. A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability. Bonzanni M; DiFrancesco JC; Milanesi R; Campostrini G; Castellotti B; Bucchi A; Baruscotti M; Ferrarese C; Franceschetti S; Canafoglia L; Ragona F; Freri E; Labate A; Gambardella A; Costa C; Rivolta I; Gellera C; Granata T; Barbuti A; DiFrancesco D Neurobiol Dis; 2018 Oct; 118():55-63. PubMed ID: 29936235 [TBL] [Abstract][Full Text] [Related]
11. A novel KCNQ2 missense variant in non-syndromic intellectual disability causes mild gain-of-function of Kv7.2 channel. Xiong J; Chen S; Chen B; Zhang W; Chen C; Deng X; He F; Zhang C; Yang L; Wang Y; Peng J; Yin F Clin Chim Acta; 2022 May; 530():74-80. PubMed ID: 35247435 [TBL] [Abstract][Full Text] [Related]
12. Gain of function due to increased opening probability by two Nappi M; Barrese V; Carotenuto L; Lesca G; Labalme A; Ville D; Smol T; Rama M; Dieux-Coeslier A; Rivier-Ringenbach C; Soldovieri MV; Ambrosino P; Mosca I; Pusch M; Miceli F; Taglialatela M Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2116887119. PubMed ID: 35377796 [TBL] [Abstract][Full Text] [Related]
13. Reduced axonal surface expression and phosphoinositide sensitivity in K Kim EC; Zhang J; Pang W; Wang S; Lee KY; Cavaretta JP; Walters J; Procko E; Tsai NP; Chung HJ Neurobiol Dis; 2018 Oct; 118():76-93. PubMed ID: 30008368 [TBL] [Abstract][Full Text] [Related]
14. Missense variants in ANO4 cause sporadic encephalopathic or familial epilepsy with evidence for a dominant-negative effect. Yang F; Begemann A; Reichhart N; Haeckel A; Steindl K; Schellenberger E; Sturm RF; Barth M; Bassani S; Boonsawat P; Courtin T; Delobel B; ; Gunning B; Hardies K; Jennesson M; Legoff L; Linnankivi T; Prouteau C; Smal N; Spodenkiewicz M; Toelle SP; Van Gassen K; Van Paesschen W; Verbeek N; Ziegler A; Zweier M; Horn AHC; Sticht H; Lerche H; Weckhuysen S; Strauß O; Rauch A Am J Hum Genet; 2024 Jun; 111(6):1184-1205. PubMed ID: 38744284 [TBL] [Abstract][Full Text] [Related]
15. Epileptic Encephalopathy In A Patient With A Novel Variant In The Kv7.2 S2 Transmembrane Segment: Clinical, Genetic, and Functional Features. Soldovieri MV; Ambrosino P; Mosca I; Miceli F; Franco C; Canzoniero LMT; Kline-Fath B; Cooper EC; Venkatesan C; Taglialatela M Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295832 [TBL] [Abstract][Full Text] [Related]
16. NEXMIF variants are associated with epilepsy with or without intellectual disability. Ye ZL; Yan HJ; Guo QH; Zhang SQ; Luo S; Lian YJ; Ma YQ; Lu XG; Liu XR; Shen NX; Gao LD; Chen Z; Shi YW Seizure; 2024 Mar; 116():93-99. PubMed ID: 37643945 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment. Bayat A; Iavarone S; Miceli F; Jakobsen AV; Johannesen KM; Nikanorova M; Ploski R; Szymanska K; Flamini R; Cooper EC; Weckhuysen S; Taglialatela M; Møller RS Neurotherapeutics; 2024 Jan; 21(1):e00296. PubMed ID: 38241158 [TBL] [Abstract][Full Text] [Related]
18. De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies. Manivannan SN; Roovers J; Smal N; Myers CT; Turkdogan D; Roelens F; Kanca O; Chung HL; Scholz T; Hermann K; Bierhals T; Caglayan HS; Stamberger H; ; Mefford H; de Jonghe P; Yamamoto S; Weckhuysen S; Bellen HJ Brain; 2022 Jun; 145(5):1684-1697. PubMed ID: 34788397 [TBL] [Abstract][Full Text] [Related]